StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
NNH.ST$13.90+1.38%
Fair $13.90+0.0%

NNH.ST

New Nordic Healthbrands AB (publ)

Consumer Defensive / Packaged FoodsStockholm

$13.90

+0.20 (+1.38%)

Fairly Valued+0.0%Fair Value $13.90Fund rank 28/100 · Data gapFallback financials|
SA 35/D
F-Score: 6/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 19%

FCF escenarios

weak_data · normalized FCF $4.9M · quality 49.0/100

Data gap 28/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 23/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

35/100

D

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · NNH.STLocal privado en este navegador · New Nordic Healthbrands AB (publ)
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$86M

P/E

32.3x

↑

EV/EBITDA

6.0x

↓

ROE

7.9%

↑

Gross Margin

64.3%

↑

Debt/Equity

0.32

↓
52-Week Range$14
$14$28

TradingView lightweight chart

NNH.ST price, volumen y niveles de valoración

Último $14.70Periodo -73.0%
Fair value: $13.90

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+5.7%

FCF CAGR

—

FCF margin

0.9%

FCF / Net income

0.60x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $576.4M · net income $8.2M · FCF $4.9M

2022-FY → 2025-FY

Gross margin

64.3%-1.1% pts

Operating margin

2.6%+3.6% pts

Net margin

1.4%+2.0% pts

FCF margin

0.9%+4.6% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$576.4M$576.4M$550.3M$533.8M$487.5M
Net Income$8.2M$8.2M$-7.7M$-6.2M$-2.8M
EBITDA$17.1M$17.1M$-1.4M$-1.8M$-2.0M
EPS——-1.24-1.00-0.46
Gross Margin64.3%64.3%64.5%65.2%65.3%
Operating Margin2.6%2.6%-0.8%-0.6%-1.0%
Net Margin1.4%1.4%-1.4%-1.2%-0.6%
Balance Sheet
Debt/Equity0.320.320.370.250.43
Current Ratio1.511.51———
Cash Flow
Free Cash Flow$4.9M$4.9M$-9.8M$25.0M$-18.4M
Returns
ROE7.9%7.9%-7.6%-5.8%-2.5%
Valuation
P/E32.3332.33———
EV/EBITDA6.036.03———
P/B0.830.830.930.991.60
Growth & Yield
Revenue Growth4.7%4.7%3.1%9.5%—
EPS Growth——-24.0%-117.4%—
Dividend Yield1.7%1.7%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -33.3%

Total return

-33.3%

Start / end P/E

n/dx → n/dx

EPS bridge

-1.24 → n/d

Residual

-35.0%

EPS growthn/d
Multiple reratingn/d
Dividend+1.7%
Residual / FX / buybacks / cross-term-35.0%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.